Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe). 1990

L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
Centre National de la Recherche Scientifique (CNRS) URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Spectrin alpha I/74 elliptocytosis results from abnormalities involving the "head" region of spectrin dimer. Increased susceptibility to trypsin enhances cleavage of the alpha spectrin chain, yielding an increased amount of the alpha I 74-kD fragment at the expense of the alpha I 80-kD parent fragment. Recently we showed that the mutations causing the Sp alpha I/74 abnormality may lie in the alpha- or the beta-chain, and that spectrin Culoz and spectrin Lyon were two (alpha I/74) alpha-variants, respectively. We now show that the spectrin Culoz alpha I domain undergoes prominent tryptic cleavage after Lys 42, whereas cleavage prevails after Arg 39 in spectrin Lyon. Applying the polymerase chain reaction (PCR) technique to exon 2 of the spectrin alpha I domain, we have established that the mutation responsible for spectrin Culoz is alpha I 40 Gly----Val; GGT----GTT. Applying the PCR technique to the cDNA derived from reticulocyte mRNA, we have shown that the mutation responsible for spectrin Lyon is alpha I 43 Leu----Phe; CTT----TTT. Studies of normal controls and of family members using dot blot hybridization with allele-specific oligonucleotide probes confirmed these results. Variants such as spectrin Culoz and spectrin Lyon should provide insight into a region that participates in spectrin dimer self-association and whose susceptibility to proteolysis must reflect subtle conformational changes.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004612 Elliptocytosis, Hereditary An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape. Ovalocytosis, Hereditary,Elliptocytoses, Hereditary,Hereditary Elliptocytoses,Hereditary Elliptocytosis,Hereditary Ovalocytoses,Hereditary Ovalocytosis,Ovalocytoses, Hereditary
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013049 Spectrin A high molecular weight (220-250 kDa) water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins, and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane. alpha-Spectrin,beta-Spectrin,alpha Spectrin,beta Spectrin

Related Publications

L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
April 1990, Acta crystallographica. Section B, Structural science,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
December 1992, Biopolymers,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
November 1985, Bioorganicheskaia khimiia,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
April 1994, International journal of peptide and protein research,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
June 1980, Journal of medicinal chemistry,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
April 2006, Protein expression and purification,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
April 1985, Bollettino della Societa italiana di biologia sperimentale,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
May 1996, International journal of peptide and protein research,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
April 2021, PLoS biology,
L Morlé, and A F Roux, and N Alloisio, and B Pothier, and J Starck, and L Denoroy, and F Morlé, and R C Rudigoz, and B G Forget, and J Delaunay
December 1992, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!